Ignite Creation Date:
2024-05-06 @ 6:35 PM
Last Modification Date:
2024-10-26 @ 2:50 PM
Study NCT ID:
NCT05712902
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2023-02-06
First Post:
2023-01-12
Brief Title:
DZD9008 in Pretreated Lung Cancer Patients With EGFR Exon20 Insertion Mutation
Sponsor:
Dizal Pharmaceuticals
Organization:
Dizal Pharmaceuticals
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-07-19
Start Date Type:
ACTUAL
Primary Completion Date:
2022-10-17
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-05-06
Completion Date Type:
ESTIMATED
First Submit Date:
2023-01-12
First Submit QC Date:
January 26 2023
Study First Post Date:
2023-02-06
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-01-26
Last Update Post Date:
2023-02-06
Last Update Post Date Type:
ACTUAL